The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin. 1998

K Midura-Nowaczek, and I Bruzgo, and K Worowski, and W Roszkowska-Jakimiec
Institute of Chemistry, University of Bialystok, Poland.

Derivatives of epsilon-aminocaproic acid with antifibrinolytic activity, at low concentration, do not influence the anticoagulant activity of heparin under the heparin-thrombin test conditions. At concentrations higher than 0.002 M tested compounds slightly enhance the anticoagulant action of heparin.

UI MeSH Term Description Entries
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000614 Aminocaproates Amino derivatives of caproic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the amino caproic acid structure. Aminocaproic Acids,Aminocaproic Acid Derivatives,Aminohexanoates,Aminohexanoic Acid Derivatives,Aminohexanoic Acids,Acid Derivatives, Aminocaproic,Acid Derivatives, Aminohexanoic,Acids, Aminocaproic,Acids, Aminohexanoic,Derivatives, Aminocaproic Acid,Derivatives, Aminohexanoic Acid
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

K Midura-Nowaczek, and I Bruzgo, and K Worowski, and W Roszkowska-Jakimiec
January 1967, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
K Midura-Nowaczek, and I Bruzgo, and K Worowski, and W Roszkowska-Jakimiec
December 1964, Bollettino della Societa italiana di biologia sperimentale,
K Midura-Nowaczek, and I Bruzgo, and K Worowski, and W Roszkowska-Jakimiec
January 1968, Pharmacology,
K Midura-Nowaczek, and I Bruzgo, and K Worowski, and W Roszkowska-Jakimiec
April 1995, Neonatal network : NN,
K Midura-Nowaczek, and I Bruzgo, and K Worowski, and W Roszkowska-Jakimiec
May 1969, Kardiologiia,
K Midura-Nowaczek, and I Bruzgo, and K Worowski, and W Roszkowska-Jakimiec
August 1965, The New England journal of medicine,
K Midura-Nowaczek, and I Bruzgo, and K Worowski, and W Roszkowska-Jakimiec
August 1962, Pharmaceutisch weekblad,
K Midura-Nowaczek, and I Bruzgo, and K Worowski, and W Roszkowska-Jakimiec
December 1967, British medical journal,
K Midura-Nowaczek, and I Bruzgo, and K Worowski, and W Roszkowska-Jakimiec
August 1966, Schweizerische medizinische Wochenschrift,
K Midura-Nowaczek, and I Bruzgo, and K Worowski, and W Roszkowska-Jakimiec
December 1965, Produits & problemes pharmaceutiques,
Copied contents to your clipboard!